Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study.

Publication

Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study.

Journal Paper/Review - May 12, 2023

Yurttas Timur, Djurdjevic Mirjana, Schnider Thomas, Filipovic Miodrag

Citation

Yurttas T, Djurdjevic M, Schnider T, Filipovic M. Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study. Br J Anaesth 2023

Type

Journal Paper/Review (English)

Journal

Br J Anaesth 2023

Publication Date

May 12, 2023

Issn Electronic

1471-6771

Brief description/objective

Intravenous lidocaine is used as an adjuvant analgesic agent in perioperative settings. It has been investigated in various patient populations and surgical interventions, but there are limited data on its efficacy, particularly for patients undergoing bariatric surgery. Obese patients are at high risk of postoperative respiratory complications and can be expected to benefit from anaesthetic techniques that minimise opioid administration.